Status:
COMPLETED
Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias
Lead Sponsor:
Oxford University Hospitals NHS Trust
Collaborating Sponsors:
University Hospital Birmingham
University Hospital Southampton NHS Foundation Trust
Conditions:
Cardiac Arrhythmia
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is the most common arrhythmia (irregular heart rhythm), affecting 1-2 million people in the UK. AF significantly increases the risk of an AF-related stroke, heart failure and ...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the trial.
- Male or female aged 18 years or above.
- Indication for 12-lead ECG.
Exclusion
- Unable to comply with instructions.
- Tattoos in the wrists or fingers where the device will be placed.
- Severe skin allergy to silicone (Apple Watch wrist band) or nickel allergies.
Key Trial Info
Start Date :
April 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05298553
Start Date
April 18 2022
End Date
April 1 2023
Last Update
April 11 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Univeristy Hospitals NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom, OX89DU
2
University Hospital Birmingham
Birmingham, United Kingdom
3
University Hospital Southampton
Southampton, United Kingdom